Last reviewed · How we verify

Oxytocin (Low dose) — Competitive Intelligence Brief

Oxytocin (Low dose) (Oxytocin (Low dose)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Neuropeptide agonist. Area: Psychiatry / Neurology.

marketed Neuropeptide agonist Oxytocin receptor (OXTR) Psychiatry / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Oxytocin (Low dose) (Oxytocin (Low dose)) — The University of Texas Medical Branch, Galveston. Low-dose oxytocin binds to oxytocin receptors to modulate social bonding, trust, and prosocial behaviors, with potential therapeutic effects on social dysfunction and anxiety.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxytocin (Low dose) TARGET Oxytocin (Low dose) The University of Texas Medical Branch, Galveston marketed Neuropeptide agonist Oxytocin receptor (OXTR)
VIP VIP Danish Headache Center marketed Neuropeptide agonist VIP receptor (VPAC1/VPAC2)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Neuropeptide agonist class)

  1. Danish Headache Center · 1 drug in this class
  2. The University of Texas Medical Branch, Galveston · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxytocin (Low dose) — Competitive Intelligence Brief. https://druglandscape.com/ci/oxytocin-low-dose. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: